These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1292355)

  • 1. [A clinico-experimental study of the tocolytic properties of salbupart in treating threatened abortion].
    Murashko LE; Sheveleva GA; Strel'chenko NV; Filimonov VG; Sidel'nikova VM
    Akush Ginekol (Mosk); 1992; (8-12):24-7. PubMed ID: 1292355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of threatened preterm labor with partusisten and salbupart].
    Murashko LE; Fedorov NA
    Vestn Akad Med Nauk SSSR; 1990; (5):26-9. PubMed ID: 2152446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of clofelin on uterine contractile activity (experimental and clinical research)].
    Khushvakhtova EKh; Arzhanova NO; Zaĭtseva AA
    Eksp Klin Farmakol; 1992; 55(4):23-4. PubMed ID: 1458180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of treatment of imminent premature labour with the preparation Salbupart-POLFA.
    Woytoń J; Gabryś M; Geneja M; Florjański J
    Mater Med Pol; 1989; 21(1):57-9. PubMed ID: 2634219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of Salbupart in the inhibition of uterine contractions in abortion and premature labor in comparison to Partusisten].
    Skorut S
    Wiad Lek; 1987 Jan; 40(2):86-9. PubMed ID: 3296465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hysterographic studies of uterine contractile activity during partusysten treatment of threatened late abortion and premature labor].
    Vinnyts'kyĭ OI
    Pediatr Akus Ginekol; 1979; (4):40-1. PubMed ID: 514659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of the course and management of pregnancy in placenta praevia].
    Sidorova IS; Botvin MA; Khachapuridze VV
    Sov Med; 1989; (6):108-11. PubMed ID: 2799480
    [No Abstract]   [Full Text] [Related]  

  • 8. [Uterine-placental-fetal blood flow and fetal cardiac activity during the ginipral treatment of premature labor].
    Strizhakov AN; Medvedev MV; Kovaleva LG
    Akush Ginekol (Mosk); 1993; (2):24-30. PubMed ID: 8048664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)].
    Marinov B; Damianov L; Tsache K; Atanasova B
    Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcutaneous electric nerve stimulation in the therapy of threatened abortion].
    Lysaia TN; Gorina TN; Strugatskiĭ VM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (2):34-6. PubMed ID: 1887621
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of premature labour and antagonization of the side effects of tocolytic therapy with verapamil (author's transl)].
    Gummerus M
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):334-40. PubMed ID: 605642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the direct tocolytic action of salbupart and fenoterol in the treatment of imminent premature labour.
    Szczygielski A; Zbisławska P; Cretti A; Miadzielec T; Sznura E
    Mater Med Pol; 1988; 20(3):194-6. PubMed ID: 3244294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined intensive pharmacotherapy in premature labor with habitual abortion and threatened abortion].
    Maksimov GP; Chernega MIa; Zaĭtsev LM
    Vrach Delo; 1988 Jul; (7):76-9. PubMed ID: 3188477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of uterine contraction with tocolytic agents (ritodrine). 2. Use in cases of threatened abortion, cervical incontinence and gynecologic surgery in pregnancy].
    Colombo PA; Pittino R; Pascalino MC; Quaranta S
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):431-40. PubMed ID: 7337350
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of Salbupart and Partusisten on the serum levels of insulin, glucose, sodium and potassium in pregnant women.
    Zbisławska P; Cretti A; Szczygielski A; Skoczowska M
    Mater Med Pol; 1992; 24(2):111-3. PubMed ID: 1307764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility.
    Gwehenberger B; Rist L; Huch R; von Mandach U
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):164-71. PubMed ID: 15063954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenoterol-induced hepatitis in a pregnant woman: a case report.
    Fontaine P; Géhénot M; Goffin P; Horsmans Y
    Am J Obstet Gynecol; 1996 May; 174(5):1647-8. PubMed ID: 9065147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tocolysis with the beta-adrenomimetic Partusisten in premature labor].
    Ivanov S
    Akush Ginekol (Sofiia); 1997; 36(2):9-10. PubMed ID: 9471910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A double blind study of the treatment of threatened abortion with fenoterol hydrobromide (author's transl)].
    Ruppin E; Ruppin J; Chelius HH
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):218-21. PubMed ID: 7215765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.